D. E. Shaw & Co., Inc. Zymeworks Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.43 $309,536 - $494,592	66,567 Added 303.82%	88,477 $544,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $2 Million - $3.2 Million	-415,581 Reduced 94.99%	21,910 $116,000
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $2.43 Million - $6.88 Million	405,408 Added 1263.62%	437,491 $2.87 Million
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $362,068 - $699,109	23,836 Added 289.03%	32,083 $526,000
Q3 2021 Nov 15, 2021	SELL	$27.35 - $37.28 $14,686 - $20,019	-537 Reduced 6.11%	8,247 $239,000
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $279,787 - $403,632	-10,558 Reduced 54.59%	8,784 $305,000
Q1 2021 May 17, 2021	SELL	$29.83 - $56.81 $1.46 Million - $2.78 Million	-48,944 Reduced 71.68%	19,342 $611,000
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $2.29 Million - $3.22 Million	-58,538 Reduced 46.16%	68,286 $3.23 Million
Q3 2020 Nov 16, 2020	SELL	$29.21 - $46.58 $4 Million - $6.38 Million	-136,862 Reduced 51.9%	126,824 $5.91 Million
Q2 2020 Aug 14, 2020	SELL	$33.67 - $40.0 $95,050 - $112,920	-2,823 Reduced 1.06%	263,686 $9.51 Million
Q1 2020 May 15, 2020	SELL	$24.28 - $49.8 $6.68 Million - $13.7 Million	-275,161 Reduced 50.8%	266,509 $9.45 Million
Q4 2019 Feb 14, 2020	BUY	$24.84 - $45.46 $3.6 Million - $6.59 Million	144,961 Added 36.54%	541,670 $24.6 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $29.08 $3.11 Million - $3.97 Million	136,528 Added 52.47%	396,709 $9.84 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $22.49 $3.9 Million - $5.85 Million	260,181 New	260,181 $5.72 Million
Q3 2018 Nov 14, 2018	SELL	$12.21 - $16.61 $325,042 - $442,174	-26,621 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$11.13 - $21.86 $296,291 - $581,935	26,621 New	26,621 $393,000

Others Institutions Holding ZYME

# of Institutions

Shares Held

296K

Call Options Held

Put Options Held

Strategic Wealth Advisors Group, LLC Sacramento, CA

296K
Shares

$4.34 Million
0.08% of portfolio

View Full List

About Zymeworks Inc.

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $903M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

More about ZYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account